Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00593086 · ClinicalTrials.gov registry record · NA

Virtual Reality in Burn Pain Management

A NA study of Pain and Burns, sponsored by United States Army Institute of Surgical Research.

Completed
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT00593086: Completed NA study of Pain and Burns, sponsored by United States Army Institute of Surgical Research.

NCT00593086 is a NA study of Pain and Burns that has completed, run by United States Army Institute of Surgical Research. The registered enrollment target is 26 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00593086, a NA study of Pain and Burns, has completed, sponsored by United States Army Institute of Surgical Research.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

To examine the safety and efficacy of Virtual Reality (VR) distraction therapy in burn patients experiencing severe procedural pain during wound care.

Conditions Studied

Interventions

  • PROCEDURE Pain management
  • OTHER Standard of care/no virtual reality game

Study Locations (1)

Texas

  • USAISR - Fort Sam Houston

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2007-06
Est. Completion 2012-06
Phase NA

What the finished NCT00593086 record still lists

NCT00593086 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (91% lower).

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Pain management is the first listed.

NCT00593086 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT00593086 about?

NCT00593086 is a clinical study titled "Virtual Reality in Burn Pain Management". To examine the safety and efficacy of Virtual Reality (VR) distraction therapy in burn patients experiencing severe procedural pain during wound care.

What is the current status of trial NCT00593086?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2007-06. Estimated completion is 2012-06.

What conditions does trial NCT00593086 study?

This clinical trial studies the following conditions: Pain, Burns.

What interventions are being tested in trial NCT00593086?

The interventions under investigation include: Pain management (PROCEDURE), Standard of care/no virtual reality game (OTHER).

Who is sponsoring clinical trial NCT00593086?

This trial is sponsored by United States Army Institute of Surgical Research, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00593086 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00593086's enrollment target sits among peer trials

26 318th of 374 higher than 55 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00593086, the US trial registry maintained by the National Library of Medicine. NCT00593086 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.